
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ARISTOCORT | Astellas Pharma | N-011960 DISCN | 1982-01-01 | 1 products |
| KENACORT | Delcor Asset | N-012515 DISCN | 1982-01-01 | 1 products |
| ARISTOCORT | Fosun Pharmaceutical | N-011685 DISCN | 1982-01-01 | 1 products |
| ARISTOCORT | Fosun Pharmaceutical | N-012802 DISCN | 1982-01-01 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ARISTOCORT | Astellas Pharma | N-011161 DISCN | 1982-01-01 | 5 products |
| KENACORT | Delcor Asset | N-011283 DISCN | 1982-01-01 | 4 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| KENALOG-10 | Bristol Myers Squibb | N-012041 RX | 1982-01-01 | 1 products, RLD |
| KENALOG-40 | Bristol Myers Squibb | N-014901 RX | 1982-01-01 | 1 products, RLD, RS |
| KENALOG-80 | Bristol Myers Squibb | N-014901 RX | 2019-04-12 | 1 products, RLD, RS |
| XIPERE | Bausch Health Companies | N-211950 RX | 2021-10-22 | 1 products, RLD, RS |
| NASACORT ALLERGY 24 HOUR | Sanofi | N-020468 OTC | 2013-10-11 | 1 products, RLD, RS |
| TRIESENCE | Harrow | N-022048 RX | 2007-11-29 | 1 products, RLD, RS |
| ZILRETTA | Pacira BioSciences | N-208845 RX | 2017-10-06 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| 24 hour nasal allergy | ANDA | 2025-06-09 |
| allergy nasal | ANDA | 2024-11-22 |
| allernaze | New Drug Application | 2010-11-23 |
| basic care nasal allergy | ANDA | 2022-10-13 |
| blt-25 kit | unapproved drug other | 2024-09-11 |
| bupivilog kit | unapproved drug other | 2024-12-31 |
| bupivilog procedure kit | New Drug Application | 2014-01-30 |
| calcipotriene 0.005% / triamcinolone acetonide 0.1% | unapproved drug other | 2019-05-10 |
| careone allergy relief | ANDA | 2023-10-23 |
| cortaren corticosteroid/anti-inflammatory system | ANDA | 2022-02-24 |
Expiration | Code | ||
|---|---|---|---|
TRIAMCINOLONE ACETONIDE, XIPERE, BAUSCH AND LOMB INC | |||
| 2024-10-22 | NP | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Triamcinolone Acetonide, Xipere, Bausch And Lomb Inc | |||
| 9937075 | 2034-05-02 | DP | |
| 9636332 | 2033-11-08 | U-3234 | |
| 8636713 | 2027-05-02 | U-3234 | |
| Triamcinolone Acetonide, Zilretta, Pacira Pharms Inc | |||
| 8828440 | 2031-08-04 | DP | |
| 9555048 | 2031-08-04 | U-2151 | |
| Triamcinolone Acetonide, Triesence, Harrow Eye | |||
| 8128960 | 2029-12-17 | DP | |
| 8211880 | 2029-03-10 | U-1257, U-1258 | |
Code | Description |
|---|---|
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
| J3302 | Injection, triamcinolone diacetate, per 5 mg |
| J3303 | Injection, triamcinolone hexacetonide, per 5 mg |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
| J7683 | Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7684 | Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Macular edema | D008269 | — | — | — | — | 4 | — | — | 4 |
| Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | 2 | — | — | 2 |
| Edema | D004487 | — | R60.9 | — | — | 2 | — | — | 2 |
| Retinal vein occlusion | D012170 | EFO_1001157 | H34.81 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Magnetic resonance imaging | D008279 | — | — | — | 1 | — | — | — | 1 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | 1 | — | — | — | 1 |
| Therapeutics | D013812 | — | — | — | 1 | — | — | — | 1 |
| Joint diseases | D007592 | — | M12.9 | — | 1 | — | — | — | 1 |
| Drug common name | Triamcinolone |
| INN | triamcinolone |
| Description | Triamcinolone is a C21-steroid hormone that is 1,4-pregnadiene-3,20-dione carrying four hydroxy substituents at positions 11beta, 16alpha, 17alpha and 21 as well as a fluoro substituent at position 9. Used in the form of its 16,17-acetonide to treat various skin infections. It has a role as an anti-allergic agent and an anti-inflammatory drug. It is a fluorinated steroid, an 11beta-hydroxy steroid, a 20-oxo steroid, a 21-hydroxy steroid, a 3-oxo-Delta(4) steroid, a glucocorticoid, a 17alpha-hydroxy steroid, a 16alpha-hydroxy steroid, a C21-steroid hormone, a primary alpha-hydroxy ketone and a tertiary alpha-hydroxy ketone. It derives from a hydride of a pregnane. |
| Classification | Small molecule |
| Drug class | steroids (not prednisolone derivatives) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO |
| PDB | — |
| CAS-ID | 124-94-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1451 |
| ChEBI ID | 9667 |
| PubChem CID | 31307 |
| DrugBank | DB00620 |
| UNII ID | 1ZK20VI6TY (ChemIDplus, GSRS) |















